Literature DB >> 18626795

Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?

Birgit Terjung1, Ulrich Spengler.   

Abstract

Primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) are enigmatic chronic inflammatory diseases of the liver, which are frequently associated with chronic inflammatory bowel diseases. Both types of liver disease share various distinct autoantibodies such as atypical perinuclear antineutrophil cytoplasmic antibodies (p-ANCA), and thus are considered autoimmune disorders with atypical features. The discovery that atypical p-ANCA recognize both tubulin beta isoform 5 in human neutrophils and the bacterial cell division protein FtsZ has renewed the discussion on the potential role of microorganisms in the pathogenesis of both diseases. In this paper, we review the evidence for microbial infection in PSC and AIH and discuss new concepts how cross-recognition between microbial antigens in the gut and host components by the immune system along with stimulation of pattern recognition receptors might give rise to chronic hepatic inflammatory disorders with features of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18626795     DOI: 10.1007/s12016-008-8088-8

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  145 in total

1.  Helicobacter sp. are not detectable in bile from German patients with biliary disease.

Authors:  J Rudi; A Rudy; M Maiwald; W Stremmel
Journal:  Gastroenterology       Date:  1999-04       Impact factor: 22.682

2.  The liver in ulcerative colitis; treatment of pericholangitis with tetracycline.

Authors:  J G RANKIN; R W BODEN; S J GOULSTON; W MORROW
Journal:  Lancet       Date:  1959-12-19       Impact factor: 79.321

3.  Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells.

Authors:  Miren Kerkmann; Lilian T Costa; Christine Richter; Simon Rothenfusser; Julia Battiany; Veit Hornung; Judith Johnson; Steffen Englert; Thomas Ketterer; Wolfgang Heckl; Stefan Thalhammer; Stefan Endres; Gunther Hartmann
Journal:  J Biol Chem       Date:  2004-12-08       Impact factor: 5.157

4.  Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.

Authors:  Tine Jess; Edward V Loftus; Fernando S Velayos; Karen V Winther; William J Tremaine; Alan R Zinsmeister; W Scott Harmsen; Ebbe Langholz; Vibeke Binder; Pia Munkholm; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2007-01-11       Impact factor: 10.864

5.  Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis.

Authors:  S Hardarson; D R Labrecque; F A Mitros; G A Neil; J A Goeken
Journal:  Am J Clin Pathol       Date:  1993-03       Impact factor: 2.493

6.  Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis.

Authors:  S P Mistilis; A P Skyring; S J Goulston
Journal:  Australas Ann Med       Date:  1965-11

7.  MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease).

Authors:  A J Grant; P F Lalor; S G Hübscher; M Briskin; D H Adams
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

8.  Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth.

Authors:  S N Lichtman; E E Okoruwa; J Keku; J H Schwab; R B Sartor
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  Cryptosporidiosis and the pathogenesis of AIDS-cholangiopathy.

Authors:  Xian-Ming Chen; Nicholas F LaRusso
Journal:  Semin Liver Dis       Date:  2002-08       Impact factor: 6.115

10.  Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium.

Authors:  Reinhart Seibl; Thomas Birchler; Susanne Loeliger; Johann Peter Hossle; Renate E Gay; Traudl Saurenmann; Beat A Michel; Reinhard A Seger; Steffen Gay; Roger P Lauener
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

View more
  22 in total

1.  Crosstalk of liver, bile ducts and the gut.

Authors:  Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

Review 2.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

3.  [Treatment of autoimmune liver diseases. Autoimmune hepatitis and primary sclerosing cholangitis].

Authors:  C P Strassburg; M P Manns
Journal:  Internist (Berl)       Date:  2011-12       Impact factor: 0.743

Review 4.  Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.

Authors:  John E Eaton; Jayant A Talwalkar; Konstantinos N Lazaridis; Gregory J Gores; Keith D Lindor
Journal:  Gastroenterology       Date:  2013-07-01       Impact factor: 22.682

5.  Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease.

Authors:  J Anthony Brandon; Jacqueline Perez; C Darrell Jennings; Donald A Cohen; V J Sindhava; S Bondada; Alan M Kaplan; J Scott Bryson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-15       Impact factor: 4.052

Review 6.  Pathogenesis of primary sclerosing cholangitis.

Authors:  Marion J Pollheimer; Emina Halilbasic; Peter Fickert; Michael Trauner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-12       Impact factor: 3.043

Review 7.  A Review of the Challenges Associated with the Diagnosis and Therapy of Primary Sclerosing Cholangitis.

Authors:  Mohammed Saadi; Christine Yu; Mohamed O Othman
Journal:  J Clin Transl Hepatol       Date:  2014-03-15

8.  Gut Inflammation in Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis-Contrasting Pattern of Liver-gut Cross Talk.

Authors:  Udayakumar Navaneethan
Journal:  EBioMedicine       Date:  2015-09-30       Impact factor: 8.143

Review 9.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

Review 10.  Looking into key bacterial proteins involved in gut dysbiosis.

Authors:  Xin-Yu Zeng; Ming Li
Journal:  World J Methodol       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.